Get started
Author

Hwa Yeon Ko

Observed names: HWA YEON KO, Ko, Hwa Yeon
ORCID: 0000-0001-5297-8826
Observed ORCID: 0000-0001-5297-8826
OpenAlex ID: A5103064090
Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease
2024 · Sungho Bea, Hwa Yeon Ko, et al. · Gut · 66
PDF
Sodium–Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia: A Population-Based Cohort Study
2024 · Bin Hong, Sungho Bea, et al. · Annals of Internal Medicine · 36
Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes
2023 · Hwa Yeon Ko, Sungho Bea, et al. · JAMA Network Open · 27
PDF
Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
2023 · Yunha Noh, Hwa Yeon Ko, et al. · Epidemiology and Health · 15
PDF
Treatment Patterns and Persistence Among Patients Newly Diagnosed With Migraine in South Korea: A Retrospective Analysis of Health Claims Data
2024 · Ki Yeon Kim, Hwa Yeon Ko, et al. · Journal of Clinical Neurology · 14
PDF
Incretin-based drugs and the risk of gallbladder or biliary tract diseases among patients with type 2 diabetes across categories of body mass index: a nationwide cohort study
2025 · Hwa Yeon Ko, Sungho Bea, et al. · The Lancet Regional Health - Western Pacific · 11
PDF
Association between sacubitril/valsartan and risk of dementia in patients with heart failure: a nationwide cohort study
2025 · Kyungyeon Jung, Ju Hwan Kim, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 8
PDF
Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis
2024 · Ju Hwan Kim, Dongwon Yoon, et al. · BMC Medicine · 7
PDF
Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021–2022
2024 · Dongwon Yoon, Kyungyeon Jung, et al. · Emerging infectious diseases · 6
Glucagon-like peptide-1 receptor agonists and risk of osteoarthritis among individuals with type 2 diabetes: A population-based cohort study
2026 · Minjeong Jeon, Bin Hong, et al. · Diabetes Research and Clinical Practice · 4
Risk of anaphylaxis after COVID ‐19 vaccination in South Korea: A nationwide self‐controlled case series analysis
2023 · Dongwon Yoon, Ju Hwan Kim, et al. · Allergy · 4
PDF
Risk of Kawasaki Disease/Multisystem Inflammatory Syndrome Following COVID-19 Vaccination in Korean Children: A Self-Controlled Case Series Study
2024 · Suyeon Kim, Hwa Yeon Ko, et al. · Journal of Korean Medical Science · 3
PDF
End-stage renal diseases associated with SGLT2 inhibitors versus GLP-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease
2025 · Hwa Yeon Ko, Bin Hong, et al. · Diabetes Research and Clinical Practice · 2
Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan
2025 · Hwa Yeon Ko, Philip C. M. Au, et al. · Clinical Pharmacology & Therapeutics · 2
PDF
Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea
2025 · Hwa Yeon Ko, Kyungyeon Jung, et al. · Diabetes Obesity and Metabolism · 2
PDF
Timing of Antidiabetic Medication Initiation and Risk of Cardiovascular Events and Mortality
2026 · Hwa Yeon Ko, Ju-Young Shin, et al. · JAMA Network Open · 1
Comparative hepatic effectiveness of empagliflozin vs dapagliflozin among individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
2026 · Suyeon Kim, Hwa Yeon Ko, et al. · Diabetologia
2154-P: Second-Line Antidiabetic Exposure in Early Pregnancy and Risk of Spontaneous Abortion: A Nationwide Cohort Study
2026 · YONGTAI CHO, EUN-YOUNG CHOI, et al. · Diabetes
Sodium-Glucose Cotransporter-2 Inhibitors and Risk of New-onset Depression and Adverse Depression-Related Outcomes in Patients with Type 2 Diabetes: A Population-Based Cohort Study
2026 · Suyeon Kim, Kyungyeon Jung, et al. · SSRN Electronic Journal
Risk of new-onset seizures following immunization against COVID-19: a self-controlled case-series study
2025 · Hwa Yeon Ko, Dongwon Yoon, et al. · Epidemiology and Health
PDF
Author response for "Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea"
2025 · Hwa Yeon Ko, Kyungyeon Jung, et al. · Publons reviews and discussion
Author response for "Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea"
2025 · Hwa Yeon Ko, Kyungyeon Jung, et al. · Publons reviews and discussion
Author response for "Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea"
2025 · Hwa Yeon Ko, Kyungyeon Jung, et al. · Publons reviews and discussion
Status of Awareness and Use of Real-World Data and Real-World Evidence in the Domestic Drug Approval Process: Insights from the Survey Study
2024 · Ja Yeon Yuk, Se Jung Park, et al. · Journal of Pharmacoepidemiology and Risk Management
PDF
1400-P: Hepatic Effectiveness of SGLT2 Inhibitors in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes
2024 · SUNGHO BEA, HWA YEON KO, et al. · Diabetes
Works count: 37
Citation count: 208
H-index: 7
I10-index: 6
Year
Topic
Type